All Opioids Now Subject to REMS, FDA Says

The FDA has made good on its promise to require that immediate-release opioids be subject to the same set of prescribing rules as extended-release formulations of the drugs.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply